HomeTrust Q2: NIM Expands to 4.41% and Dividend Jumps 15.4%, but Asset Quality Slips
HTB sits 29% above its 52-week low of $37.3.
Summary
HomeTrust Bancshares posted Q2 EPS of $0.94, missing Q1's $0.99, as a debt redemption loss and higher credit provisions weighed on results. Net interest margin improved to 4.41%, the dividend was raised 15.4%, and a new healthcare banking unit was launched, but nonperforming assets rose to 1.23%.
Key Events · Earnings and Guidance · HTB
-
Q2 Earnings Miss Q1
Net income of $15.6M ($0.94 diluted EPS) vs $16.8M ($0.99) in Q1 2026, driven by a $1.1M loss on junior subordinated debt redemption and a $550K increase in credit loss provision.
-
Net Interest Margin Expands
NIM rose to 4.41% from 4.31% QoQ, reflecting lower deposit costs as brokered CDs declined; net interest income increased $989K.
-
Asset Quality Deteriorates
Nonperforming assets to total assets increased to 1.23% from 1.07% QoQ; provision for credit losses rose to $920K from $370K, with net charge-offs concentrated in equipment finance.
-
Dividend Hiked 15.4%
Quarterly cash dividend raised to $0.15 per share from $0.13, payable August 27, 2026 to shareholders of record August 13.
Analysis · HTB · Finance
HomeTrust Bancshares delivered Q2 net income of $15.6 million, down from $16.8 million in Q1, as a $1.1 million loss on junior subordinated debt redemption and higher credit costs offset a stronger net interest margin. The margin expanded to 4.41% — a top-quartile level — driven by lower deposit costs. However, nonperforming assets climbed to 1.23% of total assets, and the provision for credit losses more than doubled to $920,000, signaling mounting credit stress. The board raised the dividend 15.4% to $0.15 per share and repurchased 153,606 shares, underscoring confidence in capital strength. The launch of a Healthcare Banking Division adds a new growth avenue. The mixed results — strong profitability and capital returns against deteriorating asset quality — create a nuanced picture for investors.
At the time of this filing, HTB was trading at $48.22 on NYSE in the Finance sector, with a market capitalization of approximately $810.4M. The 52-week trading range was $37.30 to $51.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.